CooperVision (COO): Utang-utang marang kapitalisasi buku

Logo korporat perusahaan CooperVision (COO)

As a leader in ophthalmology and women's health, does The Cooper Companies (COO) maintain financial stability? Examining the total debt-to-equity ratio on GURU.Markets, we see that the 0.33 level serves as a critical benchmark. Growth is driven by MiSight lenses and expansion in Asia, while operational flexibility is maintained through effective collaboration with external raw material suppliers.

The Cooper Companies - Utang-utang marang kapitalisasi buku COO (periode 04.07.2022 - 27.10.2026)
Produk merek CooperSurgical

Steady demand for The Cooper Companies (COO) vision care products allows the company to effectively manage its leverage. By analyzing the chart of debt-to-capital ratio, an investor assesses the ratio of total debt to the sum of equity and debt, which determines the financial stability and the degree of the business's dependence on external financing while maintaining growth rates.

Pesaing The Cooper Companies

Boston Scientific - Utang-utang marang kapitalisasi buku|Utang marang nilai buku edwards.com EW|Utang-utang marang kapitalisasi buku RMD (ResMed)|PODD - Utang-utang marang aset resik|ZBH: Utang-utang marang kapitalisasi buku|ALGN (Align Corp) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku Globus Medical, Inc.|Rasio utang marang kapitalisasi buku TransMedics Corp|ATEC (Alphatec) - Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik CryoLife AORT|DJO Global (ENOV) - Utang marang nilai buku|Rasio utang-utang marang kapitalisasi buku Integra LifeSciences Inc. IART|ESTA (Establishment Labs) - Utang-utang marang kapitalisasi buku|BBNX - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku IRADIMED|Rasio utang marang nilai buku Embecta Corp|TNDM - Utang marang nilai buku|Rasio utang marang aset resik AXGN|Rasio utang marang kapitalisasi buku SIBN (SI-BONE, Inc.)|Utang marang nilai buku orthofix.com (OFIX)|BVS: Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku OrthoPediatrics Corp KIDS|Treace Medical (TMCI) - Utang-utang marang kapitalisasi buku|SRTA - Rasio utang marang nilai buku|Carlsmed Inc - Utang-utang marang kapitalisasi buku|rxsight.com (RXST) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku CLPT|Utang marang nilai buku Stereotaxis Inc|Utang-utang marang kapitalisasi buku STIM|Utang-utang marang kapitalisasi buku SGHT (Sight Sciences Inc)|Rasio utang marang kapitalisasi buku Orchestra BioMed, Inc. OBIO|ANIK - Rasio utang marang kapitalisasi buku|Utang marang nilai buku InspireMD (NSPR)|ZJYL - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku VANI|XTNT (Xtant Medical) - Utang-utang marang nilai buku|NeuroOne Medical Technologies - Rasio utang marang kapitalisasi buku|Utang marang aset resik Modular Med (MODD)|Utang marang nilai buku MYO|Utang-utang marang kapitalisasi buku Envoy Medical Inc. (COCH)|Utang-utang marang kapitalisasi buku VVOS|enVVeno Corp - Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku SINTX Technologies|TNON: Rasio utang-utang marang kapitalisasi buku|LFWD (Lifeward) - Rasio utang marang kapitalisasi buku|Autonomix Medical (AMIX) - Utang marang nilai buku|Utang-utang marang kapitalisasi buku IVF (INVO Bioscience, Inc.)|Utang-utang marang nilai buku BBLG|Rasio utang marang kapitalisasi buku Axonics, Inc. AXNX|Rasio utang marang nilai buku biolase.com BIOL|Utang marang nilai buku Dynatronics (DYNT)|FNA - Utang marang modal buku|Utang marang nilai buku INVO Bio INVO